NCT05648539 Effect of Music Therapy in Mental Subhealth (EMTMS)
| NCT ID | NCT05648539 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jiangsu Province Nanjing Brain Hospital |
| Condition | Depression, Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2023-04-19 |
| Primary Completion | 2023-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2023-04-19 with a primary completion date of 2023-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Mental health is increasingly at the forefront of concerns, especially since the start of COVID-19 pandemic. However, not all individuals under mental subhealth need pharmaceutical treatment. Music Therapy (MT) can make peoples gradually relax via relaxing and soothing music, and regulate individual psychological emotions through the influence of music on individuals' cerebral cortex, hypothalamus and limbic system, further improve the mood of daily tension and anxiety. This study adopted randomized clinical trials design, with two groups of MT group and Waiting group both under mental subhealth. The MT group received music therapy and routine activities, while the Waiting group received music therapy after the therapy of MT group. Data collections were performed by trained, certified, and qualified personnel. The study aims to provide that MT is an effective intervention way to alleviate the mental subhealth state in the future.
Eligibility Criteria
Inclusion Criteria: A total of \> 5 on PHQ-9 or a total of \> 5 on GAD-7 Exclusion Criteria: Acute suicidal thoughts, With a severe or potentially confounding psychiatric disorder (e.g. psychosis, substance misuse).
Contact & Investigator
Fei Wang
STUDY CHAIR
Affiliated Nanjing Brain Hospital, Nanjing Medical University
Frequently Asked Questions
Who can join the NCT05648539 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 35 Years, studying Depression, Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05648539 currently recruiting?
Yes, NCT05648539 is actively recruiting participants. Contact the research team at zhuyuemiiu@163.com for enrollment information.
Where is the NCT05648539 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT05648539 clinical trial?
NCT05648539 is sponsored by Jiangsu Province Nanjing Brain Hospital. The principal investigator is Fei Wang at Affiliated Nanjing Brain Hospital, Nanjing Medical University. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.